PC016. Outcomes After Routine Ultrasound Usage in Percutaneous Endovascular Aortic Aneurysm Repair
Objectives: Ultrasound-guided femoral access in percutaneous endovascular aortic aneurysm repair (PEVAR) was associated with shorter operative times and fewer wound complications in single-center studies, but has not been systematically evaluated in large national databases.
Methods: We identified all patients who underwent endovascular aortic aneurysm repair (EVAR) and PEVAR (>1 groin percutaneously attempted) in the Vascular Quality Initiative between 2015 and 2017. We defined routine usage as $80% ultrasound usage in EVAR. We used multilevel logistic regression to calculate adjusted rates of successful bilateral percutaneous access (bPEVAR) among all EVARs performed by center, perioperative mortality and in-hospital complications, as well as factors associated with successful bPEVAR. In addition, we studied the trend in PEVAR, successful bPEVAR, and ultrasound usage over time.
Results: Of 17,946 total patients who underwent EVAR, 12,233 (68.2%) underwent PEVAR. Percent PEVAR performed (64.2%-72.9%), successful bPE-VAR (55.0%-64.8%), and ultrasound usage (49.4%-64.8%) increased from 2015 to 2017 (Fig) . Of the 260 centers, 12 (4.6%) performed no PEVAR. Of the remaining centers, eight (3.2%) used no ultrasound (Table) . Adjusted rate of successful bPEVAR was higher in centers that routinely used ultrasound compared with nonroutine ultrasound usage (65.4% vs 47.0%; P < .001). However, there were no differences in adjusted 30-day mortality rate between routine and nonroutine ultrasound usage (2.0% vs 2.1%, respectively; P ¼ .68) or any adjusted postoperative complication rates such as overall complications (7.6% vs 7.7%; P ¼ .81), hematoma (1.5% vs 1.6%; P ¼ .63), occlusion (0.4% vs 0.3%; P ¼ .67), wound infection (0.3% vs 0.2%; P ¼ .20), or postoperative transfusion requirement (10.5% vs 11.1%; P ¼ .465). Factors associated with higher odds of successful bPEVAR included routine ultrasound usage (odds ratio [OR], 2.16; 95% confidence interval [CI], 1.41-3.30; P < .001), male gender (OR, 1.30; 95% CI, 1.18-1.44; P < .001), and overweight BMI (OR, 1.12; 95% CI, 1.02-1.24; P ¼ .024). Whereas factors associated with lower odds of successful bPEVAR included age $75 (OR, 0.86; 95% CI, 0.77-0.97; P ¼ .015), underweight body mass index (OR, 0.76; 95% CI, 0.62-0.95; P ¼ .016), prior or current smoking (OR, 0.76; 95% CI, 0.67-0.85; P < .001), prior groin access (OR, 0.74; 95% CI, 0.68-0.85; P < .001), prior bypass (OR, 0.55; 95% CI, 0.43-0.69; P < .001), and preoperative P2Y12 antagonist use (OR, 0.89; 95% CI, 0.79-0.99; P ¼ .037).
Conclusions: Centers with routine ultrasound usage have higher rates of successful bPEVAR when performing EVARs, but no differences in 30-day mortality or postoperative complications. Those hoping to increase the percent of successful bilateral PEVAR should adopt a policy of routine ultrasound-guided PEVAR.
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